We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASXC
2676
DELISTED
Asensus Surgical, Inc.
ASXC
$10K ﹤0.01%
+601
New +$12.3K
MODN
2677
DELISTED
MODEL N, INC.
MODN
$10K ﹤0.01%
+1,163
New +$10.8K
NSTG
2678
DELISTED
NanoString Technologies, Inc.
NSTG
$10K ﹤0.01%
+432
New +$9.26K
AAIC
2679
DELISTED
Arlington Asset Investment Corp.
AAIC
$10K ﹤0.01%
690
+390
+130% +$5.96K
ATCO
2680
DELISTED
Atlas Corp.
ATCO
$10K ﹤0.01%
+1,060
New +$11.2K
SMED
2681
DELISTED
Sharps Compliance Corp
SMED
$10K ﹤0.01%
2,548
+2,254
+767% +$9.15K
EMWP
2682
DELISTED
Eros Media World PLC
EMWP
$10K ﹤0.01%
37
-11
-23% -$3.42K
JOBS
2683
DELISTED
51job Inc
JOBS
$10K ﹤0.01%
299
-1,649
-85% -$55.3K
CONE
2684
DELISTED
CyrusOne Inc Common Stock
CONE
$10K ﹤0.01%
225
+162
+257% +$7.18K
LMRK
2685
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$10K ﹤0.01%
627
+38
+6% +$591
CRAY
2686
DELISTED
Cray, Inc.
CRAY
$10K ﹤0.01%
470
+41
+10% +$844
LABL
2687
DELISTED
Multi-Color Corp
LABL
$10K ﹤0.01%
130
+30
+30% +$2.12K
BOJA
2688
DELISTED
Bojangles', Inc. Common Stock
BOJA
$10K ﹤0.01%
+542
New +$9.45K
NRCIB
2689
DELISTED
National Research Corp Class B
NRCIB
$10K ﹤0.01%
238
-134
-36% -$5.15K
IXYS
2690
DELISTED
IXYS Corp
IXYS
$10K ﹤0.01%
829
+629
+315% +$7.15K
CEMP
2691
DELISTED
Cempra, Inc.
CEMP
$10K ﹤0.01%
+3,500
New +$42.4K
PCBK
2692
DELISTED
Pacific Continental Corp
PCBK
$10K ﹤0.01%
459
-1,013
-69% -$19K
WBB
2693
DELISTED
Westbury Bancorp, Inc.
WBB
$10K ﹤0.01%
490
+485
+9,700% +$9.83K
EMG
2694
DELISTED
Emergent Capital, Inc.
EMG
$10K ﹤0.01%
8,461
+7,557
+836% +$15.4K
DTLK
2695
DELISTED
Datalink Corp
DTLK
$10K ﹤0.01%
+934
New +$10.1K
BBRC
2696
DELISTED
Columbia Beyond BRICs ETF
BBRC
$10K ﹤0.01%
680
+241
+55% +$3.71K
EMKR
2697
DELISTED
Emcore Corp
EMKR
$10K ﹤0.01%
+112
New +$7.7K
MNTX
2698
DELISTED
Manitex International, Inc.
MNTX
$10K ﹤0.01%
1,403
-470
-25% -$2.64K
WR
2699
DELISTED
Westar Energy Inc
WR
$10K ﹤0.01%
169
-7,453
-98% -$424K
FCFP
2700
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
$10K ﹤0.01%
+892
New +$9.28K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.